Insights

Strategic focus Clinical-stage biotech with cancer vaccine and targeted therapies, signaling potential partnerships or licensing opportunities with larger biopharma seeking immunotherapy assets and biosimilars.

Leadership shifts Recent leadership changes including new CEO and Chairman, plus acquisition activity, suggesting a period of strategic realignment and potential collaboration or investment discussions.

Acquisition history Acquisition of Avant Diagnostics and rebranding to Theralink Technologies indicate a trajectory of asset integration and potential cross-selling of diagnostic or companion diagnostic capabilities.

Limited scale Small company size with modest revenue, implying a need for partnership or co-development deals, contract research services, and consulting engagements to scale programs.

Regulatory readiness Engagement with regulatory and clinical research services providers and a track record of clinical development advances position the company for CRO/CSO collaborations and trial support opportunities.

OncBioMune Pharmaceuticals, Inc. Tech Stack

OncBioMune Pharmaceuticals, Inc. uses 8 technology products and services including RSS, WordPress, Mailchimp, and more. Explore OncBioMune Pharmaceuticals, Inc.'s tech stack below.

RSS

Content Management System

WordPress

Content Management System

Mailchimp

Modernizr

Javascript Libraries

PHP

Programming Languages

reCAPTCHA

Security

HTTP/3

Web & Portal Technology

Cloudflare Insights

Web Analytics

OncBioMune Pharmaceuticals, Inc. Email Formats	Example	Percentage
FLast@oncbiomune.com	JDoe@oncbiomune.com	100%

OncBioMune Pharmaceuticals, Inc. Email Formats

Example

Percentage

FLast@oncbiomune.com

JDoe@oncbiomune.com

100%

Frequently Asked Questions

What is OncBioMune Pharmaceuticals, Inc.'s phone number?

You can contact OncBioMune Pharmaceuticals, Inc.'s main corporate office by phone at

+1-225-227-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OncBioMune Pharmaceuticals, Inc.'s official website and social media links?

OncBioMune Pharmaceuticals, Inc.'s official website is oncbiomune.com and has social profiles on LinkedIn.

How much revenue does OncBioMune Pharmaceuticals, Inc. generate?

As of July 2026, OncBioMune Pharmaceuticals, Inc.'s annual revenue is estimated to be $1M - $10M.

What is OncBioMune Pharmaceuticals, Inc.'s SIC code and NAICS code?

OncBioMune Pharmaceuticals, Inc.'s SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OncBioMune Pharmaceuticals, Inc. have currently?

As of July 2026, OncBioMune Pharmaceuticals, Inc. has approximately 5 employees across 2 continents, including North America and Asia. Key team members include Ceo, Cso: J. H. and Member Of Board Of Directors: A. K. Explore OncBioMune Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does OncBioMune Pharmaceuticals, Inc. belong to?

OncBioMune Pharmaceuticals, Inc. operates in the Biotechnology industry.

What technology does OncBioMune Pharmaceuticals, Inc. use?

OncBioMune Pharmaceuticals, Inc.'s tech stack includes RSS, WordPress, Mailchimp, Modernizr, PHP, reCAPTCHA, HTTP/3 and Cloudflare Insights.

What is OncBioMune Pharmaceuticals, Inc.'s email format?

OncBioMune Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@oncbiomune.com. Find more OncBioMune Pharmaceuticals, Inc. email formats with LeadIQ.

When was OncBioMune Pharmaceuticals, Inc. founded?

OncBioMune Pharmaceuticals, Inc. was founded in 2005.

OncBioMune Pharmaceuticals, Inc.

Q: What technology does OncBioMune Pharmaceuticals, Inc. use?

OncBioMune Pharmaceuticals, Inc.'s tech stack includes Bootstrap, Twemoji, html5media, Slider Revolution, Clicky.

Q: What is OncBioMune Pharmaceuticals, Inc.'s NAICS code?

OncBioMune Pharmaceuticals, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

BiotechnologyLouisiana, United States2-10 Employees

OncBioMune Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on cancer therapies, developing immunotherapy products and targeted cancer treatments. It uses a proprietary Vaccine Technology designed to stimulate the immune system to attack cancer cells while aiming to spare patients from undue harm. The lead product, ProscaVax, was positioned to enter Phase 2 in early 2016, and the company also maintains a portfolio that includes targeted therapies, some of which are biosimilars to established drugs. The company is headquartered in Baton Rouge, Louisiana, and operates with a small team. 

In the biotechnology research landscape, OncBioMune is positioned as a developer of immunotherapy approaches for cancer and a portfolio of targeted modalities. A notable 2020 development involved completing the asset purchase of Avant Diagnostics and subsequently changing the corporate name to Theralink Technologies Inc., reflecting a strategic corporate pivot.

Insights

Similar companies to OncBioMune Pharmaceuticals, Inc.